Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance.
暂无分享,去创建一个
G. Shulman | D. Nilsson | G. Cline | You-Ree Cho | Jason K. Kim | A. Cederberg | R. Westergren | So-Young Park | Hyo-Jeong Kim | T. Higashimori | Jianying Dong | S. Enerback | Zhen-Xiang Liu
[1] Dan R. Littman,et al. PKC-θ knockout mice are protected from fat-induced insulin resistance , 2004 .
[2] G. Cline,et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. , 2004, Diabetes.
[3] H. Lodish,et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. , 2004, The Journal of clinical investigation.
[4] G. Shulman,et al. Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice. , 2003, Diabetes.
[5] G. Shulman,et al. Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.
[6] M. White,et al. SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.
[7] C. Kahn,et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. , 2002, Developmental cell.
[8] K. Petersen,et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.
[9] A. Bonen,et al. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.
[10] M. Arca,et al. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. , 2002, Diabetes.
[11] Vincent Lebon,et al. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. , 2002, Diabetes.
[12] G. Boden. Obesity, free fatty acids, and insulin resistance , 2001 .
[13] P. Carlsson,et al. FOXC2 Is a Winged Helix Gene that Counteracts Obesity, Hypertriglyceridemia, and Diet-Induced Insulin Resistance , 2001, Cell.
[14] Michael Karin,et al. Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.
[15] G. Shulman,et al. Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.
[16] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[17] U. Smith,et al. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. , 2001, Biochemical and biophysical research communications.
[18] S. Lemieux,et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. , 2001, Diabetes.
[19] G. Shulman,et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] T. Funahashi,et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. , 2001, Diabetes.
[21] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[22] G. Shulman,et al. Contrasting Effects of IRS-1 Versus IRS-2 Gene Disruption on Carbohydrate and Lipid Metabolism in Vivo * , 2000, The Journal of Biological Chemistry.
[23] C. Kahn,et al. Unraveling the mechanism of action of thiazolidinediones. , 2000, The Journal of clinical investigation.
[24] L. Chao,et al. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. , 2000, The Journal of clinical investigation.
[25] G. Cooney,et al. Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle. , 2000, The Journal of clinical endocrinology and metabolism.
[26] Young-Bum Kim,et al. Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.
[27] G. Dohm,et al. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. , 2000, Diabetes.
[28] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[29] J. Shaw,et al. Type 2 diabetes worldwide according to the new classification and criteria. , 2000, Diabetes care.
[30] S. Mudaliar,et al. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action , 2000, Diabetologia.
[31] G. Shulman,et al. On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .
[32] P. Scifo,et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. , 1999, Diabetes.
[33] G. Shulman,et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. , 1999, Diabetes.
[34] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[35] E. Kraegen,et al. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. , 1998, Metabolism: clinical and experimental.
[36] G. Shulman,et al. Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis. , 1998, Diabetes.
[37] G. Dohm,et al. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.
[38] E. Kraegen,et al. Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat , 1997, Diabetes.
[39] J. Olefsky,et al. Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes , 1996, Diabetes.
[40] Jerrold M. Olefsky,et al. Protein-tyrosine Phosphatase 1B Is a Negative Regulator of Insulin- and Insulin-like Growth Factor-I-stimulated Signaling* , 1996, The Journal of Biological Chemistry.
[41] J. Lehmann,et al. An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ) (*) , 1995, The Journal of Biological Chemistry.
[42] S. Rapoport,et al. Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. , 1994, Analytical biochemistry.
[43] C. R. Kahn,et al. Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.
[44] J. McGarry,et al. What if Minkowski had been ageusic? An alternative angle on diabetes. , 1992, Science.
[45] B. Goldstein,et al. Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. , 1992, The Journal of biological chemistry.
[46] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[47] R. DeFronzo. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.
[48] R. DeFronzo. The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.
[49] D. James,et al. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration , 1986, Diabetologia.
[50] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[51] G. Shulman,et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. , 2004, The Journal of clinical investigation.
[52] M. Heiman,et al. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. , 2004, Obesity research.
[53] G. Cooney,et al. Triglycerides, fatty acids and insulin resistance--hyperinsulinemia. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[54] C. Rondinone,et al. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. , 2001, Diabetes.
[55] L. DiPietro,et al. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.
[56] E. Kraegen,et al. Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. , 1997, Diabetes.
[57] J. Lehmann,et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). , 1995, The Journal of biological chemistry.
[58] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.